Tian An Medicare Limited Share Price Deutsche Boerse AG

Equities

SMI

BMG2133H2006

Healthcare Facilities & Services

Market Closed - Deutsche Boerse AG 07:06:51 31/05/2024 BST 5-day change 1st Jan Change
0.076 EUR -.--% Intraday chart for Tian An Medicare Limited +2.70% -10.59%

Financials

Sales 2022 1.44B 184M 170M 14.43B Sales 2023 1.57B 201M 185M 15.75B Capitalization 869M 111M 102M 8.72B
Net income 2022 -124M -15.86M -14.63M -1.24B Net income 2023 11M 1.41M 1.3M 110M EV / Sales 2022 0.82 x
Net Debt 2022 390M 49.84M 45.96M 3.91B Net cash position 2023 91.9M 11.75M 10.84M 923M EV / Sales 2023 0.5 x
P/E ratio 2022
-6.44 x
P/E ratio 2023
65.4 x
Employees 2,599
Yield 2022 *
-
Yield 2023
1.25%
Free-Float 21.4%
More Fundamentals * Assessed data
Dynamic Chart
Tian an Medicare Limited Approves Final Dividend for the Year Ended 31 December 2023 CI
China Medical & HealthCare Changes Name to Tian An Medicare MT
China Medical & Healthcare Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 02 August 2024 CI
China Medical & HealthCare Group Returns to Profit in 2023 on Higher Revenue MT
China Medical & HealthCare Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Medical & HealthCare to Return to Profit in 2023 MT
China Medical & Healthcare Group Limited Provides Earnings Guidance for Eleven Months Ended 30 November 2023 CI
China Medical & HealthCare Names New Auditor MT
China Medical & HealthCare Proposes Name Change MT
China Medical & Healthcare Group Limited Announces Company Secretary and Authorised Representative Changes CI
China Medical & HealthCare Group Limited Announces Change in the Composition of the Board of Directors and Change of Members of the Board Committees CI
Fareast Global, TACI Conclude CMH Offer; Assume Control of Target MT
China Medical & Healthcare Group Limited Announces Resignation of Chong Sok Un as Executive Director and Deputy Chairman and Change in Composition of the Board Committees CI
Tian An China Investments Company Limited (SEHK:28) completed the acquisition of 18.13% stake in China Medical & HealthCare Group Limited from its shareholders for approximately HKD 180 million. CI
China Medical & HealthCare Group's H1 Attributable Loss Narrows MT
More news
1 week+2.70%
1 month+1.33%
3 months+5.56%
6 months-15.08%
Current year-10.59%
More quotes
1 week
0.07
Extreme 0.072
0.08
1 month
0.07
Extreme 0.0705
0.08
Current year
0.06
Extreme 0.063
0.10
1 year
0.06
Extreme 0.063
0.11
3 years
0.05
Extreme 0.05
0.32
5 years
0.05
Extreme 0.05
0.58
10 years
0.05
Extreme 0.05
1.54
More quotes
Managers TitleAgeSince
Director/Board Member 58 26/10/22
Members of the board TitleAgeSince
Director/Board Member 60 09/10/23
Director/Board Member 64 07/12/16
Chairman 55 09/10/23
More insiders
Date Price Change Volume
31/05/24 0.076 -.--% 0
30/05/24 0.076 -2.56% 0
29/05/24 0.078 +1.96% 120
28/05/24 0.0765 +6.25% 0
27/05/24 0.072 -2.70% 3,000

Delayed Quote Deutsche Boerse AG, May 31, 2024 at 07:06 am

More quotes
Tian An Medicare Ltd, formerly China Medical & HealthCare Group Ltd, is an investment holding company principally engaged in the healthcare business. The Company operates its business through six segments. The Healthcare segment is engaged in the operation of hospitals in China. The Eldercare segment is engaged in the property development of independent living units and project management of health campus in China with focus on elderly care and retirement community, which consist of an elderly nursing home, service apartments, independent living units and a commercial area comprising a shopping mall, retail shops and club hall facilities. The Property Development segment is engaged in the development and sale of properties and land. The Property Investment segment is engaged in the leasing of residential and office properties. The Financial Services segment provides loan financial services. The Securities Trading and Investments is engaged in the trading of securities.
More about the company